Invention Grant
- Patent Title: Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
- Patent Title (中): 含有用于药物组合物的取代烷基的噻吩并嘧啶
-
Application No.: US13035023Application Date: 2011-02-25
-
Publication No.: US08853193B2Publication Date: 2014-10-07
- Inventor: Armin Heckel , Frank Himmelsbach , Joerg Kley , Thorsten Lehmann-Lintz , Norbert Redemann , Achim Sauer , Leo Thomas , Dieter Wiedenmayer , Phillip Black , Wesley Blackaby , Ian Linney , Matthias Austen , John Danilewicz , Martin Schneider , Kay Schreiter
- Applicant: Armin Heckel , Frank Himmelsbach , Joerg Kley , Thorsten Lehmann-Lintz , Norbert Redemann , Achim Sauer , Leo Thomas , Dieter Wiedenmayer , Phillip Black , Wesley Blackaby , Ian Linney , Matthias Austen , John Danilewicz , Martin Schneider , Kay Schreiter
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Priority: EP10154930 20100226
- Main IPC: C07D495/04
- IPC: C07D495/04 ; A61K31/519 ; A61K31/5377 ; A61K31/56 ; A61P29/00 ; A61P35/00 ; A61P25/28 ; A61P13/12 ; A61K31/395
Abstract:
The present invention relates to novel thienopyrimidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
Public/Granted literature
- US20110212103A1 THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS Public/Granted day:2011-09-01
Information query
